| Dimetridazole |
![]() Last updated: 16/09/2025 |
![]() |
(Also known as: DMZ) |
|
|
|
An anti-fungal and anti-protozoal substance used for the control of infection, mostly in birds | |
|---|---|---|
|
Mainly used to manage diarrhea, inflammatory bowel disease and general infections | |
|
Pigs; Game birds; Pigeons; Caged birds |
| Approval status |
|
Not approved | |
|---|---|---|
|
Not approved |
| Chemical structure |
|
None | |
|---|---|---|
|
C₅H₇N₃O₂ | |
|
CC1=NC=C(N1C)[N+](=O)[O-] | |
|
No data | |
|
IBXPYPUJPLLOIN-UHFFFAOYSA-N | |
|
InChI=1S/C5H7N3O2/c1-4-6-3-5(7(4)2)8(9)10/h3H,1-2H3 | |
|
Yes |
|
|
| Common Name | Relationship | Link |
|---|---|---|
| dimetridazole | - | ![]() |
| General status |
|
Antiparasitic, Bactericide, Fungicide, Coccidiostat, Feed additive | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nitroimidazole | ||||||||||||||
|
- | ||||||||||||||
|
- | ||||||||||||||
|
Synthetic | ||||||||||||||
|
Works by targeting DNA, where it undergoes reductive activation inside anaerobic organisms. Once activated, dimetridazole forms reactive intermediates that bind to DNA, causing strand breaks and inhibition of nucleic acid synthesis, ultimately leading to cell death | ||||||||||||||
|
[DNA, Reductive activation] | ||||||||||||||
|
551-92-8 | ||||||||||||||
|
209-001-2 | ||||||||||||||
|
- | ||||||||||||||
|
371200 | ||||||||||||||
|
- | ||||||||||||||
|
Antiparasitic products, insecticides & repellents: Agents against protozoal diseases | ||||||||||||||
|
QP51AA07 | ||||||||||||||
|
No | ||||||||||||||
|
Prohibited | ||||||||||||||
|
141.13 | ||||||||||||||
|
- | ||||||||||||||
|
1,2-dimethyl-5-nitroimidazole | ||||||||||||||
|
1,2-dimethyl-5-nitro-1H-imidazole | ||||||||||||||
|
|
||||||||||||||
|
- | ||||||||||||||
|
- | ||||||||||||||
|
Evidence of use in third world countries; Not approved as a feed additive in EU | ||||||||||||||
|
White to pale-yellow crystalline powder | ||||||||||||||
| Commercial |
|
|
|||
|---|---|---|---|---|
|
Banned in many countries | |||
|
Circa 1955, first synthesis; 1990, first EU listing; 2010s, banned Canada, EU & USA | |||
|
|
|||
|
|
|||
|
Usually administered as a feed or water additive | |||
|
Dimetridazole is synthesised through a multi-step chemical process starting with 2-methyl-5-nitroimidazole as the key intermediate. In one common method, this compound is reacted with dimethyl sulphate in the presence of formic acid. After the reaction, the formic acid is removed via vacuum distillation, and the residue is dissolved in water and neutralised using aqueous ammonia. Cooling the solution to near 0 DegC allows unreacted material to precipitate and be removed. The remaining solution is then adjusted to a basic pH, which facilitates the isolation of dimetridazole. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
|
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
18300 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) 3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
322 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
2.04 X 1000 | Calculated | - | |||||||
|
0.31 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) 3 = Unverified data of known source |
Low | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
1.426 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
|
2.6 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
| - | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
Substance may enter the environment via the faeces of treated animals or by leaching from spilt medicated feed. | ||||||||||
| Degradation |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- | ||||||||||
| Soil adsorption and mobility |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
| Fate indices |
|
|
|
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - | |||||||||||||||||||||||||||
| Known soil and groundwater metabolites |
None
| Other known metabolites |
|
|
|
|
||||
|---|---|---|---|---|---|---|---|
| 2-hydroxymethyl-1-methyl-5-nitroimidazole | HMMNI | Animal (Urine); Turkeys (Tissue) | - | ||||
| 1-methyl-5-nitroimidazol-2-yl methyl hydrogen sulphate | - | Turkeys (Tissue) | - | ||||
| 1-methyl-5-nitroimidazol-2-yl methyl carboxylic acid | MNICA | Turkeys (Tissue) | - |
|
|
| Terrestrial ecotoxicology |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
1600 | P5 P = Other non-EU, UK or US Governments and Regulators Rat5 = Verified data used for regulatory purposes |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
| - | |||||||||||
|
- | - | - | ||||||||
| - | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- |
|
- | - | - | ||||||
|
- | ||||||||||
| Aquatic ecotoxicology |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - | ||||||||
|
|
| General |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
High (class III) | - | - | ||||||||
|
1600 | P5 P = Other non-EU, UK or US Governments and Regulators Rat5 = Verified data used for regulatory purposes |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Extensively metabolised and excreted in the urine, faeces and in expired air | P5 P = Other non-EU, UK or US Governments and Regulators 5 = Verified data used for regulatory purposes |
- | ||||||||
| Health issues |
|
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Inhalation may cause haemorrhage in lungs and cervical lymph nodes | ||||||||||||||||||||||||||||
| Handling issues |
|
|
|||
|---|---|---|---|---|
|
IMDG Transport Hazard Class 9 | |||
|
- | |||
|
Not listed (Not listed) | |||
|
UN3077 | |||
|
Packaging Group III (minor danger) | |||
|
- |
|
|
|
|
||
|---|---|---|---|
|
dimetridazole | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
dimetridazol | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
| Record last updated: | 16/09/2025 |
| Contact: | aeru@herts.ac.uk |
| Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |
© Copyright University of Hertfordshire, 2006-2026. All Rights Reserved
Your use of this website and its various databases is subject to the terms detailed in the University of Hertfordshire’s copyright and IPR statement that can be found at https://www.herts.ac.uk/about-us/legal. In addition, your use of this website and its various databases is subject to the terms of this additional Copyright Statement and the database Conditions of use document. Unless explicitly stated otherwise, the content of this website and databases are owned and controlled by the University of Hertfordshire. Site content, including its selection and arrangement, is owned by the University of Hertfordshire and is protected by copyright and other laws. Except as otherwise expressly permitted under copyright law or within the database Conditions of Use document, the content of this site may not be copied, reproduced, republished, downloaded, posted, broadcast or transmitted in any way without first obtaining the University of Hertfordshire’s written permission. By using our databases the user is deemed to have agreed to comply with all of the terms and conditions as described above and within all relevant documentation.





